Quality of Life Improvement with Sublingual Immunotherapy: A Prospective Study of Efficacy
Table 4
Mean RQLQ Scores Presublingual Immunotherapy and at Subsequent Visits.
Category sum
Round 1
Round 2
Round 3
Mean (SE)
Mean (SE)
Mean (SE)
Activity sum
8.14
(.57)
4.92*
(.44)
4.63*
(.52)
Sleep sum
5.84
(.68)
3.61
(.45)
3.92
(.63)
Non-nose/eye sum
17
(1.37)
10.59*
(1.04)
10.71*
(1.22)
Practice problem sum
8.43
(.65)
4.63*
(.50)
5.06*
(.54)
Nasal symptom sum
11.69
(.74)
7.25*
(.60)
7.63*
(.64)
Eye symptom sum
8.92
(.82)
5.49*
(.67)
6.16*
(.67)
Emotional sum
10.55
(.87)
4.27*
(.59)
4.82*
(.67)
*Denotes RQLQ domains found to have a statistically significant decrease in symptom scores throughout the duration of sublingual immunotherapy treatment. *.
